Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAd63-MVA ME-TRAP malaria vaccine efficacy study
PACTR201303000499409Completed
- Sponsor
- University of Oxford
- Start
- Jun 2012
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of ChAd63 ME-TRAP and MVA ME-TRAP in malaria, sponsored by University of Oxford. Primary endpoint: Vaccine efficacy. Started Jun 2012; status: completed.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201303000499409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201303000499409.